Amphoteric liposomes and their use
View Patent ↗Amphoteric liposomes are proposed, which comprise positive and negative membrane-based or membrane-forming charge carriers as well as the use of these liposomes.
1. Amphoteric liposomes comprising an active ingredient, having an isoelectric point of between 4 and 7, wherein the liposomes comprise at least one amphipatic cationic lipid, at least one amphipatic anionic lipid, and at least about 30% neutral lipid, and wherein said liposomes are stable at pH 4.2 and pH 7.5.
2. The amphoteric liposomes of claim 1 , wherein the liposomes have an isoelectric point of between 5 and 7.
3. Amphoteric liposomes comprising an active ingredient, wherein the liposomes comprise at least one amphipatic lipid with both a positive charge and a negative charge, and at least about 30% neutral lipid, wherein the amphoteric liposomes have an isoelectric point of between 4 and 8 and are stable at pH 4.2 and pH 7.5.
4. The amphoteric liposomes of claim 3 , wherein the liposomes further comprise at least one amphipatic lipid with a positive charge or at least one amphipatic lipid with a negative charge.
5. Amphoteric liposomes of claim 3 , wherein the liposomes have an isoelectric point between 5 and 7.
6. The amphoteric liposomes of claim 1 , 2 , 3 , 4 , or 5 , wherein said neutral lipid is selected from the group consisting of phosphatidyl choline, phosphatidyl ethanolamine, cholesterol, tetraether lipid, ceramide, sphingolipid, and diacyl glycerol.
7. The amphoteric liposomes of claim 1 or 3 , wherein the liposomes have an average size of between 50 and 1000 nm.
8. The amphoteric liposomes of claim 1 , wherein the active ingredient is a protein, a peptide, a DNA, and RNA, antisense nucleotide and or a decoy nucleotide.
9. The amphoteric liposomes of claim 1 , wherein at least 80 percent of the active ingredient is in the interior of the liposome.
10. The amphoteric liposomes of claim 7 , wherein the liposomes have an average size of between 70 and 250 nm.
11. The amphoteric liposomes of claim 7 , wherein the liposomes have an average size of between 60 and 130 nm.
12. Amphoteric liposomes of claim 1 wherein the anionic lipid is a weak anion and the cationic lipid is a strong cation and the anion is present in excess over the cation.
13. Amphoteric liposomes of claim 12 , wherein said weakly anionic lipid is selected from the group consisting of cholesterol hemisuccinate (CHEMS), diacyl glycerol hemisuccinate, fatty acids and phosphatidyl serine.
14. Amphoteric liposomes of claim 12 , wherein said strongly cationic lipid is selected from the group consisting of DOTAP, DC-Chol, DORIE, DDAB, TC-Chol, DOTMA, DOGS, (C18) 2 Gly + N,N-dioctadecylamido-glycin, CTAB, CPyC and DOEPC.
15. Amphoteric liposomes of claim 12 , wherein the anionic lipid is CHEMS or diacylglycerol hemisuccinate, the cationic lipid is DOTAP or DC-Chol and the neutral lipid is phosphatidylcholine.
16. Amphoteric liposomes of claim 12 , wherein said liposome comprises about 50 mol. % POPC, about 20 mol. % DOTAP and about 30 mol. % CHEMS.
17. Amphoteric liposomes of claim 12 , wherein said liposome comprises about 50 mol. % POPC, about 10 mol. % DOTAP and about 40 mol. % CHEMS.
18. Amphoteric liposomes of claim 12 , wherein said liposome comprises about 60 mol. % POPC, about 10 mol. % DOTAP and about 30 mol. % CHEMS.
19. Amphoteric liposomes of claim 12 , wherein said liposome comprises about 60 mol. % POPC, about 15 mol. % DOTAP and about 25 mol. % CHEMS.
20. Amphoteric liposomes of claim 12 , wherein said liposome comprises about 30 mol. % POPC, about 30 mol. % DOTAP and about 40 mol. % CHEMS.
21. Amphoteric liposomes of claim 12 , wherein said liposome comprises about 60 mol. % POPC, about 15 mol. % DC-Chol and about 25 mol. % CHEMS.
22. Amphoteric liposomes of claim 1 , wherein the anionic lipid is a weak anion and the cationic lipid is a weak cation.
23. Amphoteric liposomes of claim 22 , wherein said weakly anionic lipid is selected from the group consisting of cholesteryl hemisuccinate (CHEMS), diacyl glycerol hemisuccinate, fatty acids and phosphatidyl serine.
24. Amphoteric liposomes of claim 22 , wherein said weakly cationic lipid is selected from the group consisting of HisChol and MoChol.
25. Amphoteric liposomes of claim 22 , wherein said weakly anionic lipid is CHEMS or diacylglycerol hemisuccinate, said weakly cationic lipid is HisCRol or MoChol and the neutral lipid is phosphatidylcholine.
26. Amphoteric liposomes of claim 22 , wherein said liposome comprises about 55 mol. % POPC, about 40 mol. % HisChol and about 5 mol. % CHEMS.
27. Amphoteric liposomes of claim 22 , wherein said liposome comprises about 60 mol. % POPC, about 20 mol. % HisChol and about 20 mol. % CHEMS.
28. Amphoteric liposomes of claim 1 , wherein the anionic lipid is a strong anion and the cationic lipid is a weak cation and the cation is present in excess over the anion.
29. Amphoteric liposomes of claim 28 , wherein said strongly anionic lipid is selected from the group consisting of cholesterol sulphate, cholesterol phosphate, phosphatidyl glycerol, phosphatidic acid, phosphatidyl inositol, cetyl phosphate.
30. Amphoteric liposomes of claim 28 , wherein said weakly cationic lipid is selected from the group consisting of HisChol and MoChol.
31. Amphoteric liposomes of claim 28 , wherein said strongly anionic lipid is selected from phosphatidylglycerol, phosphatidic acid, or cetyl phosphate and said weakly cationic lipid is selected from HisChol or MoChol and the neutral lipid is phosphatidylcholine.
32. Amphoteric liposomes of claim 28 , wherein said liposome comprises about 47,5 mol. % POPC, about 40 mol. % HisChol and about 12,5 mol. % DPPG.